Study some of inflammatory indicator with corona patient and relation with chronic disease
Article Sidebar
Main Article Content
Abstract
The coronavirus disease epidemic of 2019 (COVID-19) is a scientific, medical, and societal problem.in modern study the investigation of viral pathogenetic pathways, as well as cellular and organ damage, involves the implementation of novel biomarkers. The study showed increased of level of sugar in a significant relationship between patients with COVID-19 and patients with diabetes mellitus at P>0.01, On the other hand, the study demonstrated an increase in the rate of D - dimer in patients infected with Covid - 19,.as well as the rate of some inflammatory markers such as acute phase protein(CRP) and WBC at P>0.05 ,The following chemical makers LDH ,ferritin) significantly higher levels in COVID-19-infected individuals than in the Control group. Screening, clinical treatment, and major complication prevention would all benefit from effective biomarkers.
Article Details
References
- Coronavirus COVID - 19 (2019 nCoV) bda7594740fd40299423467b48e9ecf6 [Internet]. [cited 2020 Sep 13]. Available from:-
- Wu C., Chen X., Cai Y., Xia J., Zhou X., Xu S. Risk factors associated with Acute respiratory distress Syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180:934-943. [PMC free article] [PubMed] [Google Scholar]
- Bin S.Y., Heo J.Y., Song M.S., Lee J., Kim E.H., Park S.J. Environmental contamination and viral shedding in MERS patients during MERS-CoV outbreak in South Korea. Clin Infect Dis. 2015;62:755-760. [PMC free article] [PubMed] [Google Scholar]
- Hunter C.A., Jones S.A. IL-6 as a keystone cytokine in health and disease. Nat Immunol. 2015;16:448-457. Erratum in: Nat Immunol 2017;18:1271. [PubMed] [Google Scholar]
- Wang L. C-reactive protein levels in the early stage of COVID - 19. Med Mal Infect 2020;50:332-4. [PMC free article] [PubMed] [Google Scholar]
- Dingerdissen HM, Bastian F, Vijay-Shanker K, et al. . OncoMX: a knowledgebase for exploring cancer biomarkers in the context of related cancer and healthy data. JCO Clin Cancer Inform 2020;4:210-20.
- Hunter C.A., Jones S.A. IL-6 as a keystone cytokine in health and disease. Nat Immunol. 2015;16:448-457. Erratum in: Nat Immunol 2017;18:1271. [PubMed] [Google Scholar]xcf
- Wang L. C-reactive protein levels in the early stage of COVID - 19. Med Mal Infect 2020;50:332-4. [PMC free article] [PubMed] [Google Scholar]
- Herold T., Jurinovic V., Arnreich C. Elevated levels of interleukin-6 and CRP predict the need for mechanical ventilation in COVID - 19 [published online ahead of print, 2020 May 18] J Allergy Clin Immunol. 2020
- Uchide N, Ohyama K, Bessho T, Toyoda H. Lactate dehydrogenase leakage as a marker for apoptotic cell degradation induced by influenza virus infection in human fetal membrane cells. Intervirology. 2009;52(3):164-73.
- Pan F, Ye T, Sun P, Gui S, Liang B, Li L, et al. Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID - 19) pneumonia. Radiology. 2020;295(3):715-21.
- Wu J, Liu J, Zhao X, Liu C, Wang W, Wang D, Xu W, Zhang C, Yu J, Jiang B,et al. Clinical Characteristics of Imported Cases of COVID - 19 in Jiangsu Province: A Multicenter Descriptive Study. Clin Infect Dis. 2020;29:ciaa199.
-Tao R.J., Luo X.L., Xu W. Viral infection in community acquired pneumonia patients with fever: a prospective observational study. J Thorac Dis. 2018;10(7):4387-4395. [PMC free article] [PubMed] [Google Scholar]
- Hodgson K, Morris J, Bridson T, Govan B, Rush C, Ketheesan N. Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections. Immunology. 2015;144(2):171-185.
- Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003;289(21):2801-2809
- Muller MC, Meijers JC, Vroom MB. Utility of thromboelastography and/or thromboelastometry in adults with sepsis: A systematic review. Crit Care. 2014;18:R30. [PMC free article] [PubMed] [Google Scholar]
- Querol-Ribelles JM, Tenias JM, Grau E, Querol-Borras JM, Climent JL, Gomez E, et al. Plasma D - dimer levels correlate with outcomes in patients with community-acquired pneumonia. Chest. 2004;126: 1087-1092. pmid:15486368
- Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID - 19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395: 1054-1062. pmid:32171076
-Chau D, Edelman SV. Clinical management of diabetes in the elderly. Clin Diabetes. 2001;19:172-5. [Google Scholar
- Ali N. Is SARS-CoV-2 associated with liver dysfunction in COVID-19 patients? Clin Res Hepatol Gastroenterol. 2020. 10.1016/j.clinre.2020.05.002
Wang G, Wu C, Zhang Q, et al. C-reactive protein level may predict the risk of COVID-19 aggravation. Open Forum Infect Dis. 2020;7(5). 10.1093/ofid/ofaa153 -
-Y. Zhu, Z. Du, Y. Zhu, W. Li, H. Miao, Z. Li. Evaluation of organ function in patients with severe COVID - 19 infections. Med Clin (Barc), (2020),
-Boyer Chammard T, Schepers K, Breurec S, Messiaen T, Destrem AL, Mahevas M, Soulillou A, Janaud L, Curlier E, Herrmann-Storck C, Hoen B. Severe thrombocytopenia after Zika virus infection, Guadeloupe, 2016. Emerg Infect Dis. 2017;23(4):696-698. doi: 10.3201/eid2304.161967.
- Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, Xie C, Ma K, Shang K, Wang W, Tian DS. Dysregulation of immune response in patients with coronavirus 2019 (COVID - 19) in Wuhan, China. Clin Infect Dis. 2020;71(15):762-768. doi: 10.1093/cid/ciaa248. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
-Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-20.